Abstract
Chromosome analysis has become an important diagnostic tool in the assessment of patients with multiple myeloma. Conventional cytogenetic analysis of myeloma cells is complicated by the difficulty in inducing myeloma cells to divide. A method for the culture and harvest of bone marrow samples from patients with myeloma is presented together with a protocol for producing G-banded metaphases for microscopic analysis. It is recommended that two or more cultures be established from each sample. There is extensive literature describing the use of various cocktails of mitogens to assist in obtaining dividing myeloma cells with little consensus as to the optimal method. A protocol is given for stimulating cells to divide using interleukin-4, the method in routine use in the Victorian Cancer Cytogenetics Service.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Liang W., Hopper J. E., and Rowley J. D. (1979) Karyotypic abnormalities and clinical aspects of patients with multiple myeloma and related paraproteinemic disorders. Cancer 44, 630–644.
Dewald G. W., Kyle R. A., Hicks G. A., and Greipp P. R. (1985) The clinical significance of cytogenetic studies in 100 patients with multiple myeloma, plasma cell leukemia or amyloidosis. Blood 66, 380–390.
Lai J. L., Zandecki M., Mary J. Y., et al. (1995) Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis. Blood 85, 2490–2497.
Smadja N. V., Louvet C., Isnard F., et al. (1995) Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques. Br. J. Haematol. 90, 619–624.
Brigadeau C., Trimoreau F., Gachard N., et al. (1997) Cytogenetic study of 30 patients with multiple myeloma: comparison of 3 and 6 day bone marrow cultures stimulated or not with cytokines by using a miniaturized karyotypic method. Br. J. Haematol. 96, 594–600.
Nilsson T., Lenhoff S., Turesson I., et al. (2002) Cytogenetic features of multiple myeloma: impact of gender, age, disease phase, culture time, and cytokine stimulation. Eur. J. Haematol. 68, 345–353.
Hernandez J. M., Gutièrrez N. C., Almeida J., et al. (1998) IL-4 improves the detection of cytogenetic abnormalities in multiple myeloma and increases the proportion of clonally abnormal metaphases. Br. J. Haematol. 103, 163–167.
Tricot G., Barlogie B., Jagannath S., et al. (1995) Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 1 1q and not with other karyotype abnormalities. Blood 86, 4250–4256.
Seong C., Delasalle K., Hayes K., et al. (1998) Prognostic value of cytogenetics in multiple myeloma. Br. J. Haematol. 101, 189–194.
Desikan R., Barlogie B., Sawyer J., et al. (2000) Results of high-dose therapy for 1000 patients with multiple myeloma: durable complete remissions and superior survival in the absence of chromosome 13 abnormalities. Blood 95, 4008–4010.
Zojer N., Konigsberg R., Ackermann J., et al. (2000) Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridisation. Blood 95, 1925–1930.
Smadja N. V., Bastard C., Brigaudeau C., Lerouz D., and Fruchart C., on behalf of the Groupe Francais de Cytogenetique Hematologique. (2001) Hypodiploidy is a major prognostic factor in multiple myeloma. Blood 98, 2229–2238.
Fassas A. B. T., Spencer T., Sawyer J., et al. (2002) Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. Br. J. Haematol. 118, 1041–1047.
Fonseca R., Blood E. A., Oken M. M., et al. (2002) Myeloma and the t(11;14) (q13;q32): evidence for a biologically defined unique subset of patients. Blood 99, 3735–3741.
Robillard N., Avet-Loiseau H., Garand R., et al. (2003) CD20 is associated with a small mature plasma cell morphology and t(11;14) in multiple myeloma. Blood 102, 1070–1071.
Mitelman F. (ed.). (1995) ISCN (1995): An International System for Human Cytogenetic Nomenclature, S. Karger, Basel, Switzerland.
Barch M. J., Knutsen T., and Spurbeck J. (eds.). (1997) The AGT Cytogenetics Laboratory Manual, 3rd ed. Lippincott-Raven, Philadelphia.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Campbell, L.J. (2005). Conventional Cytogenetics in Myeloma. In: Brown, R.D., Ho, P.J. (eds) Multiple Myeloma. Methods in Molecular Medicine™, vol 113. Humana Press. https://doi.org/10.1385/1-59259-916-8:37
Download citation
DOI: https://doi.org/10.1385/1-59259-916-8:37
Publisher Name: Humana Press
Print ISBN: 978-1-58829-392-3
Online ISBN: 978-1-59259-916-5
eBook Packages: Springer Protocols